Correlation Between Akari Therapeutics and Biophytis
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Biophytis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Biophytis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Biophytis, you can compare the effects of market volatilities on Akari Therapeutics and Biophytis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Biophytis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Biophytis.
Diversification Opportunities for Akari Therapeutics and Biophytis
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akari and Biophytis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Biophytis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biophytis and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Biophytis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biophytis has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Biophytis go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Biophytis
If you would invest 98.00 in Akari Therapeutics PLC on December 26, 2024 and sell it today you would earn a total of 32.54 from holding Akari Therapeutics PLC or generate 33.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Akari Therapeutics PLC vs. Biophytis
Performance |
Timeline |
Akari Therapeutics PLC |
Biophytis |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Akari Therapeutics and Biophytis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akari Therapeutics and Biophytis
The main advantage of trading using opposite Akari Therapeutics and Biophytis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Biophytis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biophytis will offset losses from the drop in Biophytis' long position.Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Biophytis vs. NRx Pharmaceuticals | Biophytis vs. NRX Pharmaceuticals | Biophytis vs. Akari Therapeutics PLC | Biophytis vs. Armata Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |